The Critical Role of Diagnostics and Sample Integrity
Recent data from the UK Health Security Agency highlights a concerning resurgence of measles across England in early 2026. Since January, over 150 laboratory-confirmed cases have been reported, with the majority concentrated in London and the West Midlands, and predominantly affecting children under 10 years of age.
Why Measles Remains a Public Health Priority
Measles is one of the most contagious viral diseases, capable of spreading rapidly in under-vaccinated populations. Outbreaks are often driven by gaps in immunisation coverage, with the World Health Organization recommending at least 95% vaccination uptake to maintain herd immunity.
In the current UK outbreak, transmission is particularly evident in school-aged children, reinforcing the importance of rapid identification, isolation, and public health intervention.
However, while vaccination remains the cornerstone of prevention, laboratory diagnostics and surveillance are equally critical in outbreak control.
The Role of Laboratory Testing in Outbreak Management
Guidance from the Centres for Disease Control and Prevention emphasises that laboratory confirmation is essential for:
- Differentiating measles from other febrile rash illnesses
- Confirming suspected cases quickly
- Supporting epidemiological investigations
- Monitoring transmission patterns and identifying new strains
Accurate and timely diagnostics enable health authorities to implement targeted interventions, limit spread, and better understand outbreak dynamics.
Supporting Diagnostics with Robust Sample Collection
In outbreak scenarios, the quality and integrity of the sample are just as important as the analytical method itself. Poor sample collection or transport can delay diagnosis, reduce sensitivity, and compromise surveillance data.
This is where MWE’s solutions play a vital role.
SIGMA-VIROCULT® – Reliable Viral Sample Transport
Designed for the collection and transport of viral specimens, SIGMA VIROCULT® helps preserve viral viability from point of collection through to laboratory analysis.
In the context of measles, this supports:
- Accurate initial diagnosis through reliable specimen preservation
- Consistent results across decentralised or high-throughput testing environments
- Reduced risk of sample degradation, particularly during transport
SIGMA-MM™ – Enabling Safe and Scalable Molecular Workflows
For laboratories handling high volumes of suspected cases, SIGMA MM™ offers an additional advantage. Its inactivation and stabilisation capabilities support:
- Safe handling of infectious samples
- Rapid molecular testing workflows
- Stabilisation of nucleic acids for downstream analysis
Crucially, this also enables epidemiological tracking, including sequencing efforts to monitor viral evolution and transmission pathways.
From Diagnosis to Surveillance: Enabling Outbreak Control
Effective outbreak response depends on more than identifying individual cases. It requires:
- Scalable testing capacity
- Reliable sample transport systems
- Compatibility with molecular and automated workflows
- High-quality data to inform public health decisions
By supporting both frontline diagnostics and downstream molecular analysis, solutions like SIGMA-VIROCULT® and SIGMA-MM™ contribute to a more coordinated and effective response.
Rethinking Your Outbreak Response Strategy
The current measles outbreak is a reminder that even vaccine-preventable diseases can quickly re-emerge when immunity gaps exist. While increasing vaccination uptake remains essential, diagnostic readiness and laboratory infrastructure are equally critical components of outbreak management.
Ensuring that every sample collected is fit for purpose (preserved, stabilised, and ready for analysis) can make a measurable difference in how quickly outbreaks are detected, understood, and contained.
Supporting Your Laboratory Through Outbreak Response
From sample collection to molecular workflows, our experts are ready to help you strengthen your diagnostic pathway.
